"Vascular Health's Role in Alzheimer's: New Blood Biomarker Unveiled"
Researchers from the University of Pittsburgh School of Medicine have discovered that the progression of Alzheimer's disease is influenced by astrocytes, star-shaped brain cells, in addition to amyloid aggregates. By testing the blood of over 1,000 cognitively unimpaired elderly individuals, the study found that those with a combination of amyloid burden and blood markers of abnormal astrocyte activation were more likely to develop symptomatic Alzheimer's in the future. This breakthrough challenges the belief that amyloid alone triggers the disease and highlights the importance of considering astrocyte reactivity as a biomarker for early diagnosis and drug development.